These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5642581)

  • 1. Respiratory characteristics of maternal and fetal blood in cyanotic congenital heart disease.
    Novy MJ; Peterson EN; Metcalfe J
    Am J Obstet Gynecol; 1968 Mar; 100(6):821-8. PubMed ID: 5642581
    [No Abstract]   [Full Text] [Related]  

  • 2. Obstetric complications when the fetus has congenital heart disease. II. Clinical considerations.
    Macafee J; Beischer NA; Fortune DW
    Am J Obstet Gynecol; 1971 Aug; 110(7):891-5. PubMed ID: 5558971
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy and congenital heart disease--maternal and fetal outcome.
    Sawhney H; Suri V; Vasishta K; Gupta N; Devi K; Grover A
    Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):266-71. PubMed ID: 9761150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BLOOD GASOMETRY IN FETAL BLOOD. CLINICAL AND THERAPEUTIC DEDUCTIONS (55 CASES)].
    CHOSSON J; LAVAL P; FELICIANO JM; VANDENHAUTE C; ANDRAC ; LEONARDI
    Mars Med; 1963; 100():841-60. PubMed ID: 14108634
    [No Abstract]   [Full Text] [Related]  

  • 5. [Maternal cardiopathy and perinatal mortality].
    Berlingieri D; Celentano C
    Arch Ostet Ginecol; 1978; 83(1-2):19-29. PubMed ID: 575620
    [No Abstract]   [Full Text] [Related]  

  • 6. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease.
    Whittemore R; Hobbins JC; Engle MA
    Am J Cardiol; 1982 Sep; 50(3):641-51. PubMed ID: 7113941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turner's phenotype: pregnancy and cyanotic congenital heart disease.
    Miller AP; Stonechipher HK; Boyd B
    JAMA; 1970 Dec; 214(13):2337. PubMed ID: 5536896
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytochemical characteristics of erythrocytes of the peripheral blood in children with congenital heart defects of the cyanotic type].
    Musatova TI; Vysotskaia TA; Dmitrieva VA; Fal'kovskaia AE; Tsvetkova EI
    Pediatriia; 1973 Aug; 52(8):67-8. PubMed ID: 4782732
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pregnancy in a woman with heart disease: maternal and fetal problems].
    Lo Cicero G; Brina A; Pardi G
    Ann Ostet Ginecol Med Perinat; 1973 Mar; 94(3):201-8. PubMed ID: 4790338
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congenital heart disease and acquired valvular lesions in pregnancy].
    Horstkotte D; Fassbender D; Piper C
    Herz; 2003 May; 28(3):227-39. PubMed ID: 12756480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of children with congenital heart disease.
    Feldt RH; Strickler GB; Weidman WH
    Am J Dis Child; 1969 May; 117(5):573-9. PubMed ID: 4181126
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancy and adult congenital heart disease.
    Karamermer Y; Roos-Hesselink JW
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):859-69. PubMed ID: 17867916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus.
    Presbitero P; Somerville J; Stone S; Aruta E; Spiegelhalter D; Rabajoli F
    Circulation; 1994 Jun; 89(6):2673-6. PubMed ID: 8205680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEART DISEASE IN PREGNANCY.
    EHRENFELD EN; BRZEZINSKI A; BRAUN K; SADOWSKY E; SADOWSKY A
    Obstet Gynecol; 1964 Mar; 23():363-71. PubMed ID: 14128464
    [No Abstract]   [Full Text] [Related]  

  • 15. Fetal morbidity following potentially anoxigenic obstetric conditions. 3. Prolapse of the umbilical cord.
    Niswander KR; Friedman EA; Hoover DB; Pietrowski H; Westphal M
    Am J Obstet Gynecol; 1966 Jul; 95(6):853-9. PubMed ID: 5949531
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease.
    Cordina RL; Celermajer DS
    Cardiol Young; 2010 Jun; 20(3):242-53. PubMed ID: 20416139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal morbidity following potentially anoxigenic obstetric conditions. V. Organic heart disease.
    Niswander KR; Berendes H; Deutschberger J; Lipko N; Westphal MC
    Am J Obstet Gynecol; 1967 Jul; 98(6):871-6. PubMed ID: 6027717
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology.
    Sliwa K; van Hagen IM; Budts W; Swan L; Sinagra G; Caruana M; Blanco MV; Wagenaar LJ; Johnson MR; Webb G; Hall R; Roos-Hesselink JW;
    Eur J Heart Fail; 2016 Sep; 18(9):1119-28. PubMed ID: 27384461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new aspect of the role of blood 5'-adenosine triphosphate in fetal and neonatal hypoxia.
    Bacigalupo G; Saling E
    Am J Obstet Gynecol; 1972 Nov; 114(5):631-8. PubMed ID: 4678382
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of maternal cardiovascular pathology of the fetal state and development of the newborn].
    Zuev TF
    Vopr Okhr Materin Det; 1968 Jan; 13(1):34-8. PubMed ID: 5752812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.